Shubham Pant, MD: So, Larry, when you first met Dr. Morse, what kind of questions did you have for him? You had done all your research before or did you do it after? Larry Pleasant: No, I hadn’t. I ...

A carcinoid tumor is a type of cancer that develops in different parts of the body and is characterized by a slow growth phase. Credit: Photomicrograph of a carcinoid tumor. Credit: David ...

The Patient Access Network (PAN) Foundation today opened a new patient assistance program for people living with carcinoid syndrome. Carcinoid syndrome occurs when an underlying carcinoid tumor ...

Dear Dr. Roach: Can you please give more insight into carcinoid syndrome? In particular, I'd like to know its symptoms and how it gets diagnosed and treated? What kind of a doctor would one see with ...

That FDA has approved Xermelo (telotristat ethyl) tablets as the first oral treatment for carcinoid syndrome diarrhea in combination with somatostatin analog (SSA) therapy in adults inadequately ...

THE patient with the malignant carcinoid syndrome is confronted with a group of uncomfortable and debilitating symptoms. These may include recurrent acute flushing, colicky abdominal pains, violent ...

Rochester, MN - A study conducted to identify factors involved in the progression of cardiac lesions seen in carcinoid syndrome suggests that serotonin is the main culprit and that the risk of ...

(BPT) - Ten years ago, Hollywood actress and producer Christina Simpkins was going about her regular activities – eating a healthy diet, writing, making films and practicing yoga. Then, Christina ...

A 66-year-old woman was first admitted to the Mayo Clinic on April 13, 1962, because of a mass in the neck that she had noted accidentally 2 months previously. She had had no significant symptoms, and ...

Identifying latent factors in the Living With Cancer (LWC) patient-reported outcomes (PRO) tool for patients with advanced malignancies. The role of annual personal health visits (APHV) on patients' ...

(RTTNews) - Crinetics Pharmaceuticals Inc. (CRNX) has begun its pivotal Phase 3 trial of Paltusotine in adults with carcinoid syndrome, dubbed CAREFNDR. Carcinoid syndrome affects about 20% of ...

The PAN Foundation's new program aids carcinoid syndrome patients by covering treatment-related out-of-pocket costs, addressing financial barriers to care. Eligible patients can receive up to $6,700 ...